According to the initial report, a patient is undergoing a surgery revision due to an infection of a right madibular implant.The device was implanted on (b)(6) 2021 and the infection was reported on july 27th.Requests for additional information were made to no avail.The product was not returned for evaluation.The lot number was traced and a review of the manufacturing records were performed.There were no non-conformances identified and no deviations were documented throughout the processing of the device.A review of the sterility process and results was conducted.All sterility processing specifications were met and the lal results were well below the limit.As no additional information was received, the investigation remains inconclusive.A definitive root cause could not be determined.Conclusively, infarction is a known inherent risk of any surgical procedure.The instructions for use list superficial and/or deep infection as a possible adverse effect.
|